Introduction {#Sec1}
============

Mistletoe (*Viscum* L.) belongs to the family of Viscaceae. In Europe, Asia, Africa and Australia, about 100 species of mistletoe can be distinguished, of which the most known are in Santalaceae: *Viscum album* L. (European mistletoe), Santalaceae: *Viscum album* subsp. *Coloratum* Kom. (*Viscum coloratum* (Kom.) Nakai, Korean mistletoe), Santalaceae: *Viscum articulatum* Burm. f., Santalaceae: *Viscum shimperi* Engl., Santalaceae: *Viscum capense* L.f. and Santalaceae: *Viscum cruciatum* Sieber ex Boiss. Mistletoe is a semi-parasitic evergreen shrub, which means it depends on having water and some nutrients supplied from another plant (host tree) while it produces carbohydrates in a process of photosynthesis. *Viscum* species inhabit many types of wooded habitats and parasitize both deciduous and coniferous trees (Bussing [@CR13]). For clinical applications, the most popular species are mistletoe parasitizing fir, maple, almond, birch, hawthorn, ash, apple, pine, poplar, oak, willow, lime and elm (Kienle et al. [@CR72]). *Viscum* species have been used in the traditional medicine of Europe for centuries. Hippocrates used mistletoe to treat diseases of the spleen and complaints associated with menstruation, while Pliny the Elder used it to treat epilepsy, infertility and ulcers. In the Middle Ages, Paracelsus recommended mistletoe as a treatment for epilepsy. Hildegard von Bingen described mistletoe as a treatment for diseases of the spleen and liver. Mistletoe was also applied for deworming children, to treat labour pains, gout, affections of the lungs and liver, leprosy, mumps, fractures and hepatitis. During the eighteenth century, mistletoe was applied for "weakness of the heart" and oedema (Bussing [@CR13]). By the end of the nineteenth century, mistletoe was rejected by scientists as a folklore remedy. The scientific interest on mistletoe was awakened in the twentieth century, as Gaultier investigated the effect of oral or subcutaneous applications of fresh *Viscum album* L. extracts on blood pressure in humans and animals (Bussing [@CR13]; Committee on Herbal Medicinal Products [@CR18]). In 1920, *Viscum album* L. was introduced as a cancer treatment by Rudolf Steiner who recommended a drug extract produced in a complicated manufacturing process combining sap from mistletoe harvested in the winter and summer (Bussing [@CR13]). Mistletoe was also commonly used in other parts of the world. In Japan, mistletoe was used to treat hypertension, spasms of the heart, rheumatic pain, threatened abortion and locally to treat frostbite. In India, a tea prepared from mistletoe leaves was used to treat diabetes, while a preparation of *Viscum articulatum* Burm. f. was given in fevers with aching limbs. In Africa, *Viscum* species were a remedy to treat diarrhoea and an enema for stomach troubles in children. In Israel, *Viscum cruciatum* Sieber ex Boiss. was commonly used to treat constipation in young children and adults. Mistletoe was also used against general pain, backache and arthritis. In the traditional medicine of Egypt, the plant was used for the treatment of epilepsy, arteriosclerosis, and diseases of cardiac arteries, and as a hypotensive (Bussing [@CR13]; Lev et al. [@CR95]; Committee on Herbal Medicinal Products [@CR18]). Such varied pharmaceutical applications result from the rich chemical composition of *Viscum* species, which largely depend on the host species. The main active compounds are lectins, viscotoxins, flavonoids, phenolic acids, sterols, lignans, terpenoids, phenylpropanoids, alkaloids and fatty acids (Szurpnicka et al. [@CR152]). In this review, we would like to summarize the scientific data on the pharmacological activity of *Viscum* species and analyse the probable mechanisms of actions of mistletoe.

Anticancer and immunomodulatory activity {#Sec2}
========================================

In German-speaking countries, mistletoe has been used as complementary anticancer therapy for more than 100 years. *Viscum album* L. preparations can be divided into phytotherapeutic extracts standardized on a certain lectin level (brand names such as Cefalektin, Eurixor, Lektinol) and anthroposophical/homeopathically produced extracts (brand names such as Abnoba*Viscum*, Helixor, Iscador, Iscucin, Isorel) (Freuding et al. [@CR33]). The main anticancer compounds isolated from *Viscum* species are lectins (Thies et al. [@CR156]; Eggenschwiler et al. [@CR23]) and viscotoxins (Schaller et al. [@CR136]). Later studies have shown that other compounds, such as phenolic compounds (Melo et al. [@CR99]), triterpene acids (Delebinski et al. [@CR20]) and non-polar compounds (Ćebović et al. [@CR14]), have also shown antitumor properties. Furthermore, it was reported that complete mistletoe extract is more potent at inhibiting tumour cells than isolated compounds (Felenda et al. [@CR31]), and there is synergistic action between different groups of mistletoe compounds (Twardziok et al. [@CR162]; Kleinsimon et al. [@CR84]). Mistletoe shows bi-directional activity in the treatment of cancer. Firstly, it affects the quality of life of cancer patients by the improvement of fatigue, sleep, exhaustion, nausea, vomiting, appetite, depression, anxiety, pain and side effects of traditional treatment (Kienle and Kiene [@CR73]; Brandenberger et al. [@CR12]; Kim et al. [@CR78]). Secondly, it shows antitumor activity by cytotoxicity, induction of apoptosis (Ćebović et al. [@CR14]; Park et al. [@CR128]; Han et al. [@CR47]; Mishra et al. [@CR101]) and inhibition of angiogenesis (Park et al. [@CR127]; Elluru et al. [@CR25]). The mechanism of action is shown in Fig. [1](#Fig1){ref-type="fig"}. In vitro studies on anticancer activity of mistletoe have confirmed that it modulates many different pathways, playing key roles in tumour proliferation, including MAPK (mitogen-activated protein kinase) (Park et al. [@CR128]) and PI3K/AKT (phosphatidylinositol 3-kinase/protein kinase B) (Fan et al. [@CR30]). Furthermore, mistletoe can cause cell cycle arrest (Dela Cruz et al. [@CR19]; Kim et al. [@CR82]; Melo et al. [@CR99]), loss of mitochondrial membrane permeability (MMP) (Mishra et al. [@CR101]) and can activate caspases and regulate pro- and anti-apoptotic proteins (Fan et al. [@CR30]) (Table [1](#Tab1){ref-type="table"}). The anticancer activity of *Viscum* species is linked with their immunomodulatory activity (Oei et al. [@CR112]), such as the increase of maturation and activation of dendritic cells (Elluru et al. [@CR26]; Kim et al. [@CR77]; Steinborn et al. [@CR148]), abrogation of tumour-induced immunosuppression of dendritic cells (Steinborn et al. [@CR148]), increase of leukocytes, eosinophils, granulocytes (Huber et al. [@CR55], [@CR53]) and lymphocytes (Semiglasov et al. [@CR140]), increase of cytokines secretion (Hajto et al. [@CR46]; Kovacs [@CR88]; Elluru et al. [@CR26]), increase of activity of natural killer cells (Hajto [@CR45]; Tabiasco et al. [@CR153]; Braedel-Ruoff [@CR11]; Kim et al. [@CR83]), increase of the activities of natural killer cells during surgery (Schink et al. [@CR137]) and enhancement of cellular and humoral immune response (Yoon et al. [@CR169]; Gardin [@CR34]). Clinical studies were done on patients suffering from cancer diseases such as bladder cancer, breast cancer, colorectal cancer, glioma, lung cancer, melanoma and the results of these studies have been published in many articles. Those who are interested in the topic are invited to read review articles focusing on the anti-cancer properties of mistletoe (Ernst et al. [@CR28]; Bar-Sela [@CR9]; Bar-Sela et al. [@CR10]; Steele et al. [@CR147]; Kienle et al. [@CR74]; Schläppi et al. [@CR138]; Freuding et al. [@CR33]). Additionally, it is worth paying attention to studies regarding synergistic interactions of mistletoe preparations with other cancer treatments such as chemotherapy and radiotherapy (Siegle et al. [@CR145]; Hong et al. [@CR52]; Kleinsimon et al. [@CR84]; Schötterl et al. [@CR139]; Menke et al. [@CR100]). Furthermore, we found research that Korean mistletoe lectin affected the self-renewal activity of placenta-derived mesenchymal stem cells (MSCs) (Choi et al. [@CR15]; Kim et al. [@CR76]), however its therapeutic use for cancer is still insufficiently investigated (Hmadcha et al. [@CR51]).Fig. 1Mechanism of anticancer activity of mistletoe. Mistletoe targets two important signalling pathways, PI3K/AKT and MAPK. PI3K/AKT pathway is responsible for growth and survival of cancer cells. Mistletoe induces apoptosis by inhibition of AKT phosphorylation. MAPK pathway is mediated by ERK, p38 and JNK. Mistletoe enhances p38 and JNK1 activation and reduces ERK leading to apoptosis and cell cycle arrest of cancer cells. **a** Mistletoe downregulates cyclins (CCND1, CCNE, CCNA) and cyclin-dependent protein kinases (CDK4, CDK2) inhibiting cell cycle. **b** Mistletoe upregulates proapoptotic proteins (Bax) and downregulates inhibitors of apoptosis (IAPs) such as BCL2, BCL2L1, MCL1, XIAP. Furthermore, mistletoe leads to release of cytochrome c and activation of caspases resulting in apoptosisTable 1Antitumor activity of *Viscum* species---in vitro studiesMechanism of actionPreparation/compound (host tree)Concentration of the extract/compoundCell lineObservationsReferencesCell cycle*Viscum album* L. (apple tree)Extract containing 10 ng/mL lectin MLIExtract containing 60 µg/mL oleanolic acidExtract containing 5 ng/mL lectin MLI and 50 µg/mL oleanolic acidHuman osteosarcoma cell lines 143B, Saos-2 and U2OSG1 arrest in TP53 wild-type (U2OS) and null-mutant (Saos-2) cells, S arrest in TP53 mutant cells (143B), blockage of G1/S transition accompanied by downregulation of CDK4, CCND1, CDK2, CCNE, CCNA, investigations on the transcriptional level revealed secondary TP53 participation, cell cycle arrest was mediated by transcriptionally increased expression of GADD45A and CDKN1A and decreased SKP2 levelsKleinsimon et al. ([@CR85])*Viscum album* L3% and 5% v/vMurine melanoma cell line B16F10Increased Sub G0 population, probably associated with a consistent decrease in G1, and an increase in S or G2/M populationsMelo et al. ([@CR99])*Viscum articulatum* Burm. f. (*Dalbergia latifolia* Roxb*.*)0.015--150 µg/mLHuman leukemia cell lines Jurkat E6.1 and THP1G2/M cell cycle arrest with a concomitant decrease in some cells at G0/G1 phaseMishra et al. ([@CR101])1,7-Bis(4-hydroxyphenyl)-1,4-heptadien-3-one isolated from *Viscum coloratum* (Kom.) Nakai2.5--20 µMHuman lung cancer cell lines A549 and NCI-H292Cell cycle arrest in A549 and NCI- H292 cells at the S and G0/G1 phases, respectivelyFan et al. ([@CR30])*Viscum coloratum* (Kom.) NakaiLectin 10--1000 ng/mLExtract 10--1000 µg/mLMouse melanoma cell lines B16BL6 and B16F10G0/G1 cell cycle arrestHan et al. ([@CR47])MMP*Viscum articulatum* Burm. f. (*Dalbergia latifolia* Roxb*.*)0.015--150 µg/mLHuman leukemia cell lines Jurkat E6.1 and THP1Loss of MMP, which is required for cytochrome c releaseMishra et al. ([@CR101])*Viscum album* L(apple tree)Extract containing 1.25--7.5 ng/mL lectin MLIExtract containing 30--45 µg/mL oleanolic acidExtract containing 1.25--7.5 ng/mL lectin MLI and 30--45 µg/mL oleanolic acidHuman alveolar Rhabdomyosarcoma cell line RMS-13Stammer et al. ([@CR146])*Viscum album* L(apple tree)Extract containing 1--40 ng/mL lectin MLIExtract containing 10--60 µg/mL oleanolic acidExtract containing 1--40 ng/mL lectin MLI and 10--60 µg/mL oleanolic acidHuman Ewing sarcoma cell lines TC-71 and MHH-ES-1Twardziok et al. ([@CR162])*Viscum album* L. (apple tree)Extract containing 2--16 ng/mL lectin MLIExtract containing 20--40 µg/mL oleanolic acidExtract containing 2--16 ng/mL lectin MLI and 20--40 µg/mL oleanolic acidHuman acute myeloid leukemia cell lines U937 and HL-60Delebinski et al. ([@CR20])1,7-Bis(4-hydroxyphenyl)-1,4-heptadien-3-one isolated from *Viscum coloratum* (Kom.) Nakai2.5--20 µMHuman lung cancer cell lines A549 and NCI-H292Fan et al. ([@CR30])*Viscum album* L. (apple tree)Extract containing 2.5--10 ng/mL lectin MLIExtract containing 40--60 µg/mL oleanolic acid Extract containing 2.5--10 ng/mL lectin MLIand 40--60 µg/mL oleanolic acidHuman osteosarcoma cell lines 143B and Saos-2Kleinsimon et al. ([@CR84])Cytochrome *c* and AIF*Viscum album* L. (apple tree)Extract containing 4--8 ng/mL lectin MLIExtract containing 25--35 µg/mL oleanolic acidExtract containing 4--8 ng/mL lectin MLI and 25--35 µg/mL oleanolic acidHuman acute myeloid leukemia cell lines U937 and HL-60Release of cytochrome cDelebinski et al. ([@CR20])1,7-Bis(4-hydroxyphenyl)-1,4-heptadien-3-one isolated from *Viscum coloratum* (Kom.) Nakai2.5--20 µMHuman lung cancer cell lines A549 and NCI-H292Release of cytochrome c and AIFFan et al. ([@CR30])MAPK/JNK, ERK and p38Lectin II isolated from *Viscum coloratum* (Kom.) Nakai100 ng/mLHuman myeloid leukemia cell line U937Increased phosphorylation of the JNK1 substrate, GST-c-Jun N-terminal proteinPark et al. ([@CR126])Abnoba*Viscum* F (ash)20 µg/mLHuman myeloid leukemia cell line K562Increased phosphorylation of JNK1 and p38, reduced levels of phosphorylated ERK-1/2Park et al. ([@CR128])*Viscum album* L. (apple tree)Extract containing 1--40 ng/mL lectin MLIExtract containing 10--60 µg/mL oleanolic acidExtract containing 1--40 ng/mL lectin MLI and 10--60 µg/mL oleanolic acidHuman Ewing sarcoma cell lines TC-71 and MHH-ES-1Increased phosphorylation of JNK1 and p38Twardziok et al. ([@CR163])*Viscum album* L. (apple tree)Extract containing 10 ng/mL lectin MLIExtract containing 60 µg/mL oleanolic acidExtract containing 5 ng/mL lectin MLI and 50 µg/mL oleanolic acidHuman osteosarcoma cell lines 143B, Saos-2 and U2OSActivation of JNK1 with simultaneous inactivation of ERK-1/2Kleinsimon et al. ([@CR85])1,7-Bis(4-hydroxyphenyl)-1,4-heptadien-3-one isolated from *Viscum coloratum* (Kom.) Nakai2.5--20 µMHuman lung cancer cell lines A549 and NCI-H292Upregulation of the expression levels of p-ERK1/2 and p-P90RSKFan et al. ([@CR30])PI3K/AKT1,7-Bis(4-hydroxyphenyl)-1,4-heptadien-3-one isolated from *Viscum coloratum* (Kom.) Nakai2.5--20 µMHuman lung cancer cell lines A549 and NCI-H292Downregulation of the phosphorylation of AKT and P70RSKFan et al. ([@CR30])Lectin isolated from *Viscum coloratum* (Kom.) Nakai10 ng/mLHuman cancer cell line A253Dephosphorylation of AKTChoi et al. ([@CR16])Iscador Qu Spezial (oak)Iscador M (apple tree)0.3 mg/mLHuman tongue cancer cell lines SCC9 and SCC25Reduced pAKTKlingbeil et al. ([@CR86])Abnoba*Viscum* F (ash)20 µg/mLHuman myeloid leukemia cell line K562Reduced levels of phosphorylated AKTPark et al. ([@CR128])COX-2VA Qu Spez (oak)10--100 µg/mLHuman lung adenocarcinoma cell line A549Inhibition of the secretion of IL-1β-induced PGE2 associated with a reduced expression of COX-2Hegde et al. ([@CR48]) and Saha et al. ([@CR133])Caspases*Viscum album* L. (apple tree)Extract containing 2--16 ng/mL lectin MLIExtract containing 20--40 µg/mL oleanolic acidExtract containing 2--16 ng/mL lectin MLI and 20--40 µg/mL oleanolic acidHuman acute myeloid leukemia cell line HL-60Activation of caspase-8 and caspase -9Delebinski et al. ([@CR20])*Viscum articulatum* Burm. f. (*Dalbergia latifolia Roxb.*)0.015--150 µg/mLHuman leukemia cell lines Jurkat E6.1 and THP1Activation of caspase-8 and caspase-3Mishra et al. ([@CR101])*Viscum album* L. (apple tree)Extract containing 1.25--7.5 ng/mL lectin MLIExtract containing 30--45 µg/mL oleanolic acidExtract containing 1.25--7.5 ng/mL lectin MLI and 30--45 µg/mL oleanolic acidHuman alveolar Rhabdomyosarcoma cell line RMS-13Activation of caspase-9, caspase-8 and caspase-3Stammer et al. ([@CR146])*Viscum album* L. (apple tree)Extract containing 1--40 ng/mL lectin MLIExtract containing 10--60 µg/mL oleanolic acidExtract containing 1--40 ng/mL lectin MLI and 10--60 µg/mL oleanolic acidHuman Ewing sarcoma cell lines TC-71 and MHH-ES-1Activation of caspase-9, caspase-8Twardziok et al. ([@CR162])1,7-Bis(4-hydroxyphenyl)-1,4-heptadien-3-one isolated from *Viscum coloratum* (Kom.) Nakai2.5--20 µMHuman lung cancer cell lines A549 and NCI-H292Activation of caspase-9 and caspase-3Fan et al. ([@CR30])Abnoba*Viscum* F (ash)20 µg/mLHuman myeloid leukemia cell line K562Decreased expression of procaspase-9 but increased that of cleaved (active) caspase-9Park et al. ([@CR128])Lectin isolated from *Viscum coloratum* (Kom.) Nakai10 ng/mLHuman cancer cell line A253Activation of caspase-3Choi et al. ([@CR16])*Viscum album* L. (apple tree)Extract containing 2.5--10 ng/mL lectin MLIExtract containing 40--60 µg/mL oleanolic acid Extract containing 2.5--10 ng/mL lectin MLI and 40--60 µg/mL oleanolic acidHuman osteosarcoma cell lines 143B and Saos-2Activation of caspase-8 and caspase-9Kleinsimon et al. ([@CR84])*Viscum Coloratum* (Kom.) NakaiLectin 10--1000 ng/mLExtract 10--1000 µg/mLMouse melanoma cell lines B16BL6 and B16F10Activation of caspase-1, 3, 4, 5, 6, 7, 8, and 9Han et al. ([@CR47])Antiapoptotic proteins*Viscum album* L. (apple tree)Extract containing 40 ng/mL lectin MLIExtract containing 40 µg/mL oleanolic acidExtract containing 15 ng/mL lectin MLI and 30 µg/mL oleanolic acidHuman acute myeloid leukemia cell line HL-60Downregulation of BIRC5, XIAP, p53 and claspinDelebinski et al. ([@CR20])*Viscum album* L. (apple tree)Extract containing 1--40 ng/mL lectin MLIExtract containing 10--60 µg/mL oleanolic acidExtract containing 1--40 ng/mL lectin MLI and 10--60 µg/mL oleanolic acidHuman Ewing sarcoma cell lines TC-71 and MHH-ES-1Downregulation of BIRC5, XIAP, MCL1 and CLSPN,Twardziok et al. ([@CR162])*Viscum album* L. (apple tree)Extract containing 2.5--10 ng/mL lectin MLIExtract containing 40--60 µg/mL oleanolic acid Extract containing 2.5--10 ng/mL lectin MLI and 40--60 µg/mL oleanolic acidHuman osteosarcoma cell lines 143B and Saos-2Downregulation of BIRC5, XIAP, BCL2, and CLSPNKleinsimon et al. ([@CR84])*Viscum album* L. (apple tree)Extract containing 5 ng/mL lectin MLIExtract containing 40 µg/mL oleanolic acidExtract containing 5 ng/mL lectin MLI and 40 µg/mL oleanolic acidHuman alveolar Rhabdomyosarcoma cell lines RH-30 and RMS-13Downregulation of BIRC5, XIAP, BCL2, BCL2L1 and MCL1Stammer et al. ([@CR146])*Viscum articulatum* Burm. f. (*Dalbergia latifolia Roxb.*)0.015--150 µg/mLHuman leukemia cell lines Jurkat E6.1 and THP1Downregulation of BCL2Mishra et al. ([@CR101])Lectin isolated from *Viscum coloratum* (Kom.) Nakai10 ng/mLHuman hepatocarcinoma cells SK-Hep-1 and Hep3BLyu et al. ([@CR98])Abnoba*Viscum* F (ash)20 µg/mLHuman myeloid leukemia cell line K562Downregulation of Mcl-1Park et al. ([@CR128])1,7-bis(4-hydroxyphenyl)-1,4-heptadien-3-one isolated from *Viscum coloratum* (Kom.) Nakai2.5--20 µMHuman lung cancer cell lines A549 and NCI-H292Upregulation of Bcl-2 and Bcl-xLFan et al. ([@CR30])Proapoptotic proteins*Viscum articulatum* Burm. f. (*Dalbergia latifolia Roxb.*)0.015--150 µg/mLHuman leukemia cell lines Jurkat E6.1 and THP1Upregulation of BaxMishra et al. ([@CR101])Lectin isolated from *Viscum coloratum* (Kom.) Nakai10 ng/mLHuman hepatocarcinoma cells SK-Hep-1 and Hep3BLyu et al. ([@CR98])*Viscum album* L. (apple tree)Extract containing 2.5--10 ng/mL lectin MLIExtract containing 40--60 µg/mL oleanolic acid Extract containing 2.5--10 ng/mL lectin MLI and 40--60 µg/mL oleanolic acidHuman osteosarcoma cell lines 143B and Saos-2Kleinsimon et al. ([@CR84])1,7-Bis(4-hydroxyphenyl)-1,4-heptadien-3-one isolated from *Viscum coloratum* (Kom.) Nakai2.5--20 µMHuman lung cancer cell lines A549 and NCI-H292Downregulation of BaxFan et al. ([@CR30])STAT3*Viscum album* L. (apple tree)Extract containing 10 ng/mL lectin MLIExtract containing 60 µg/mL oleanolic acidExtract containing 5 ng/mL lectin MLI and 50 µg/mL oleanolic acidHuman osteosarcoma cell lines 143B, Saos-2 and U2OSDephosphorylation of STAT3 at Tyr705 and Ser727, down-regulation of total STAT3 and its direct downstream targets BIRC5 and C-MYCKleinsimon et al. ([@CR85])Abnoba*Viscum* F (ash)5--20 µg/mLHuman hepatocellular carcinoma cell line Hep3BReduction of C-MYC protein levels which might be mediated by the ubiquitin--proteasome systemYang et al. ([@CR168])TelomeraseLectin isolated from *Viscum coloratum* (Kom.) Nakai10 ng/mLHuman cancer cell line A253Inhibition of telomerase activity through downregulation of hTERTChoi et al. ([@CR16])ROS*Viscum articulatum* Burm. f. (*Dalbergia latifolia Roxb.*)0.015--150 µg/mLHuman leukemia cell lines Jurkat E6.1 and THP1ROS mediated DNA fragmentationMishra et al. ([@CR101])1,7-Bis(4-hydroxyphenyl)-1,4-heptadien-3-one isolated from *Viscum coloratum* (Kom.) Nakai5--20 µMHuman lung cancer cell lines A549 and NCI-H292Promotion of ROS generationFan et al. ([@CR30])

Cardiac activity {#Sec3}
================

The cardiac activity of mistletoe has been confirmed in in vitro as well as in vivo studies (Committee on Herbal Medicinal Products [@CR18]; Poruthukaren et al. [@CR131]; Montero et al. [@CR103]) (Table [2](#Tab2){ref-type="table"}). Tenorio et al. ([@CR155]) and Tenorio-Lopez et al. ([@CR154]) studied the mechanism of vasodilator activity of aqueous extract of *Viscum album* L. leaves on the Langendorff's isolated and perfused heart model. They showed that mistletoe induced nitric oxide syntetaze-2 (NOS-2) and nitric oxide syntetaze-3 (NOS-3) overexpression, which was connected with increases in nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) production. Therefore, the vasodilator activity of mistletoe might be mediated by the NO/sGC pathway. Soluble guanylyl cyclase (sGC) is an enzyme catalysing the conversion of GTP to cGMP and mediating several biological functions, such as the inhibition of platelet aggregation, smooth muscle relaxation and vasodilation. NO activates sGC by directly binding to heme to form a ferrous--nitrosyl--heme complex. Once sGC is activated by NO, GTP to cGMP conversion is triggered. Exogenous and endogenous compounds produce vasodilation through increases in cGMP, which in turn, relaxes vascular smooth muscle cells by both desensitising the contractile apparatus to Ca^2+^ and lowering intracellular Ca^2+^, with the consequent activation of a protein known as cGMP-dependent protein kinase. NO, synthesised by the enzyme nitric oxide synthase (NOS), maintains a vasodilator tone that is essential for the regulation of blood flow and pressure. NOS is a heme-containing enzyme that has three isoforms, designated as NOS-1, NOS-2 and NOS-3 (Tenorio-Lopez et al. [@CR154]). Furthermore, studies on myocardial ischemia and reperfusion injury in rats as well as isoproterenol-induced heart failure in rats confirmed the cardioprotective effect of *Viscum album* L. might be mediated by the upregulation of the NO pathway (Karagöz et al. [@CR67]; Suveren et al. [@CR151]). Studies of Nω-nitro-L-arginine methyl ester (L-NAME)-induced hypertensive rats treated with methanolic extract of *Viscum articulatum* Burm. f. showed that mistletoe has an antihypertensive effect, which may be attributed to its diuretic, nephroprotective and hypolipidemic action. It was proposed the blood pressure lowering activity of this extract might have been due to the presence of triterpenoids, such as oleanolic acid and betulinic acid (Bachhav et al. [@CR6]). Oleanolic acid isolated from the cuticular wax of *Viscum articulatum* Burm. f. significantly decreased the systolic blood pressures and cardiac lipid peroxidation levels in glucocorticoid (dexamethasone)-induced hypertensive rats, which might be connected with its antioxidant and nitric oxide releasing action (Bachhav et al. [@CR8]). On the other hand, a study carried out in L-NAME-induced hypertensive rats treated with oleanolic acid showed that this compound did not affect nitric oxide levels, and its antihypertensive effect might be due to diuresis and nephroprotection (Bachhav et al. [@CR7]). Another mechanism of the antihypertension activity of *Viscum* might be mediated by the calcium channel blockade (CCB). The contractile mechanism in smooth muscle is activated by a rise in the concentration of free intracellural Ca^2+^ concentration, which activates the contractile elements. The increase in intracellular Ca^2+^ occurs via either influx from the extracellular fluid through voltage-dependant Ca^2+^ channels (VDCs) or its release from intracellular stores. Thus, vascular smooth muscle relaxant agents may produce their effects by inhibiting either or both sources of Ca^2+^ (Mojiminiyi et al. [@CR102]; Khan et al. [@CR70]). A study carried out in rat aortic rings showed that an aqueous extract of leaves of *Viscum album* L. growing on oil palm trees had vasorelaxant activity, which might be mediated by a non-specific non-competitive inhibition of Ca^2+^ influx as well as inhibition of Ca^2+^ mobilization from intracellular stores (Mojiminiyi et al. [@CR102]). Furthermore, a study carried out in rabbit aortic rings showed that vasorelaxant activity of mistletoe is mediated through a voltage-dependent Ca^2+^ channel blockade (Khan et al. [@CR70]). It was proposed that some of the actions on Ca^2+^ influx or mobilization from cellular stores observed in the study for *Viscum album* L. might be partly mediated by NO. This is because NO inhibits Ca^2+^ influx through ligand gated Ca^2+^ channels as well as release from cellular stores. Thus, it is probable that *Viscum album* L. might achieve vasorelaxation through dual mechanisms, the NO/sGC pathway as well as through Ca^2+^-dependent mechanisms (Mojiminiyi et al. [@CR102]) (Fig. [2](#Fig2){ref-type="fig"}). Ofem et al. ([@CR113]) suggested that the reduction in blood pressure without any alteration in heart rate by aqueous extract of leaves of *Viscum album* L. growing on citrus may be due to catecholamine-like blocking agent(s), showing predominantly alpha-1 adrenoceptor antagonist action or agonist-like agents that may be stimulating the beta-2 adrenoceptors to produce the depressor effect. In turn, Radenkovic et al. ([@CR132]) proposed that decreases in the blood pressure in rats treated with ethanolic extracts of *Viscum album* L. steams might be connected with muscarine cholinergic receptors. In rat models of myocardial infarction, flavonoids isolated from *Viscum coloratum* (Kom.) Nakai reduced ischemic myocardial injuries by blocking the signalling pathway of platelet-activating factor (PAF). A PAF antagonist isolated from mistletoe might be a homoeriodictyol-7-*O*-*β*-D-glucoside (Chu et al. [@CR17]). Additionally, *Viscum album* L. improved haematological parameters in rats. Mistletoe extracts reduced red blood cell count and packed cell volume (Ofem et al. [@CR114]; Ladokun et al. [@CR93]) and brought the elevated total plasma protein levels and reduced erythrocyte sedimentation rate in the high salt-fed rats to near control levels, indicating the ability of the extract to prevent marked changes in the blood viscosity (Ofem et al. [@CR114]).Table 2Pharmacological activity of *Viscum* species---in vivo studiesPharmacological activity*Viscum* species/ProductPartHost treeExtraction solventCompoundsDoseRoute of administrationStudy durationExperimental designResultsReferencesAntihypertensive activity*Viscum album* LFresh leavesCitrusAqueous150 mg/kg, dailyOrally6 weeksNormotensive, renal artery-occluded hypertensive and salt-induced hypertensive ratsDecrease in arterial blood pressure without alteration in heart rate, antihypertensive effect might involve sympathetic mechanismOfem et al. ([@CR113])*Viscum album* LFresh steamsEthanolic, ether and ethyl acetate3.33 × 10^−5^, 1.00 × 10^−4^, 3.33 × 10^−4^, 1.00 × 10^−3^ mg/kgIntraperitoneallyAtropine sulfate and hexocycline treated ratsEthanolic extract exhibited activity even on the lowest dose, the ether and ethyl acetate extracts exhibited activity only by higher doses, antihypertensive effect might involve muscarinic receptorsRadenkovic et al. ([@CR132])*Viscum album* LDried leavesPear *(Pyrus communis* auct. iber.*)*Aqueous250 mg/kg, dailyOrally by gavage24 daysIsoproterenol-induced heart failure in ratsImprovement in all parameters of heart failure including left ventricular diameters, ejection fraction, serum NT-proBNP levels and histopathological changes; decrease in levels of NO, iNOS and hs-CRPKaragöz et al. ([@CR67])*Viscum album* L0.6--2.8 g, dailyOrally6 weeksAn open study in 120 patients with light to moderate hypertension (WHO grade I-II)Decrease in systolic pressure (in rest and during physical exercise)Committee on Herbal Medicinal Products ([@CR18])*Viscum album* L5 drops of drug every 5 min up to 4 administrationsSublingually264 patients with diagnosis of hypertensionTime of arterial blood pressure reduction was less for the group of patients who received the natural treatmentMontero et al. ([@CR103])*Viscum album* L. mother tinctureEthanolic extract manufactured according to Homoeopathic Pharmacopoeia of India10 drops of drug in 30 ml of distilled water, three times a dayOrally12 weeks37 newly diagnosed hypertensive patientsDecrease in systolic and diastolic pressure, decrease in serum triglyceridePoruthukaren et al. ([@CR131])*Viscum articulatum* Burm. fDried herb*Cordia macleodii* Hook.f. & ThomsonMethanolic200 and 400 mg/kg, dailyOrally4 weeksL-NAME-induced hypertensive ratsAntihypertensive effect might be attributed to diuretic, nephroprotective and hypolipidemic actions, and might be due to the presence of triterpenoidsBachhav et al. ([@CR6])*Viscum articulatum* Burm. fCuticular waxOleanolic acid60 mg/kg, dailyIntraperitoneally15 daysGlucocorticoid (dexamethasone)-induced hypertensive ratsDecrease of the systolic blood pressure, which might be connected with its antioxidant and NO releasing actionBachhav et al. ([@CR8])*Viscum articulatum* Burm. fCuticular waxOleanolic acid60 mg/kg, daily4 weeksL-NAME-induced hypertensive ratsOleanolic acid did not affected NO level and its antihypertensive effect might be due to diuresis and nephroprotectionBachhav et al. ([@CR7])Hematological parameters*Viscum album* LFresh leavesCitrusAqueous150 mg/kg, dailyOrally6 weeksHigh salt-fed ratsDecrease in the red blood cells, packed cell volume, haemoglobin, total plasma protein levels and increase in erythrocyte sedimentation rateOfem et al. ([@CR114])*Viscum album* LDried leavesCoffee (*Coffee arabica*), kola (*Kola nitida*) and cocoa (*Theobromae cacao*)Aqueous400, 800, 1600 and 3200 mg/kg, dailyOrally14 daysHealthy ratsMistletoe parasitizing on kola significantly, in dose dependent manner, decreased platelets count, mistletoe parasitizing cocoa and coffee reduced haemoglobin concentration, all the extracts reduced packed cell volume, red blood cell and increased white blood cellsLadokun et al. ([@CR93])Antiglycemic, antilipidemic and insulinotropic effect*Viscum album* LDried leavesEthanolic250, 500, 750, 1000 mg/kg10 hNormalglycemic and streptozotocin-induced diabetic ratsReduction in fasting blood glucose levelNwaegerue et al. ([@CR110])*Viscum album* LDried herbApricot (*Armeniaca vulgaris* Lam.), pine (*Pinus nigra* J.F.Arnold), fir (*Abies bornmlleriana* Mattf.)Aqueous and ethanolic500 mg/kgOrally by gastric gavage8 daysStreptozotocin-induced diabetic ratsAntidiabetic effect of mistletoe depends on the host treeOrhan et al. ([@CR121])*Viscum album* LFresh leavesAqueous100 mg/kgIntravenously3 hNormalglycemic and streptozotocin-induced diabetic ratsNo effect on glucose level in normal rats but decrease of the blood glucose level in the diabetic rats, increase of the insulin secretion in normal rats and in the diabetic groupEno et al. ([@CR27])*Viscum album* LDried herb*Kola acuminate*Methanolic100 mg/kg, daily3 weeksStreptozotocin-induced diabetic ratsReduction in fasting blood glucose level, HbA1c, serum triglyceride, urea, lactate dehydrogenase, α-amylase and low density lipoprotein cholesterol, increase of high density lipoprotein cholesterolAdaramoye et al. ([@CR200])*Viscum album* LDried leavesEthanolic100 mg/kg, dailyOrally by gavage10 daysStreptozotocin-induced diabetic ratsNo significant difference in glucose level, reduction in oxidative stressTurkkan et al. ([@CR159])*Viscum album* LDried leavesCitrusAqueous150 mg/kg, dailyOrally with syringe and orogastric tube3 weeksStreptozotocin-induced diabetic ratsReduction in fasting blood glucose levelNna et al. ([@CR109])*Viscum album* LDried leavesOil been (*Pentaclethra macrophylla* Benth.)Aqueous200 mg/kgIntraperitoneally4 hFasted normalglycemic ratsDecrease in blood glucose levelOhiri et al. ([@CR118])400 mg/kgAlloxan-induced diabetic rabbits*Viscum album* LDried leavesOakAqueous500 and 1000 mg/kg, dailyOrally by gavage3 daysAlloxan-induced diabetic ratsDecrease in serum glucose concentration and increase in the serum insulin levelShahaboddin et al. ([@CR143])*Viscum album* LDried leavesSweet orange (*Citrus sinensis* (L.) Osbeck), african pear *(Dacroydes edulis*), guava (*Psidium guajava* L.) and pepper fruit (*Dennettia tripetala* Baker f.)Aqueous100 mg/kg, dailyOrally by gavage14 daysAlloxan-induced diabetic ratsThe strongest activity was exhibited by extracts of mistletoe growing on *Citrus sinensis* and *Pisium guajava*Umoh et al. ([@CR164])*Viscum album* LDried leavesEthanolic2 mg/kg, 16 hIntraperitoneally54 hAlloxan-induced diabetic ratsDecrease in fasting blood glucose levelIbegbulem and Chikezie [@CR57])*Viscum coloratum* (Kom.) NakaiDried herbOak (*Quercus variabilis* Blume)Protein fraction50---400 µg/mlIntraperitoneally10 daysAlloxan-induced diabetic miceDecrease in the blood glucose level and volume of drinking waterKim et al. ([@CR79])*Viscum coloratum* (Kom.) NakaiDried herbOakAqueous and ethanolicBetulin and oleanolic acidDiet containing 0.2 or 0.6% of extractOrally8 weeksPartial pancreatectomized ratsEthanolic extract made β-cell mass greater by increasing β-cell proliferation and decreasing its apoptosisKo et al. ([@CR87])*Viscum schimperi* EnglDried herbMethanolic500 mg/kg, dailyOrally by gavage4 weeksStreptozotocin-induced diabetic ratsReduction in the fasting blood glucose level; increase of the level of insulin, reduction of total cholesterol, trigliceryde and low density lipoprotein cholesterol and increase of high density lipoprotein cholesterolAbdel-Sattar et al. ([@CR2])Hepatoprotective activity*Viscum album* LLeavesEthanolic1 g/kgOrallyParacetamol-induced hepatotoxity in ratsReduction of ALT, ALP levels, no influence on the levels of total bilirubin and total proteinOgbonnanya et al. ([@CR116])*Viscum album* LDried leavesCocoa (*Theobroma cacao* L.) and cola (*Cola nitida* (Vent.) Schott & Endl.)Methanolic1000--5000 mg/kg, dailyOrogastrically7 daysParacetamol-induced hepatotoxity in ratsNo significant difference in AST, ALT and ALP for *V. album* growing on cocoa, significant increase in AST, ALT and ALP for *V. album* growing on cola at 4000 and 5000 mg/kg dosesYusuf et al. ([@CR170])*Viscum album* LDried leavesCitrusAqueous150 mg/kg, dailyOrally (syringe and or gastric tube)6 weeksHigh salt diet ratsDecrease in serum total bilirubin, serum conjugated bilirubin and serum unconjugated bilirubinOfem et al. ([@CR115])*Viscum album* LDried leavesCitrusAqueous150 mg/kg, dailyOrally (syringe and or ogastric tube)3 weeksStreptozotocin-induced diabetic ratsDecrease in serum total bilirubin, serum conjugated bilirubin and serum unconjugated bilirubinNna et al. ([@CR108])Viscum Fraxini-2 (*Viscum album* L.)AshAqueous0.1 and 0.2 ml/kg, once weeklySubcutaneously30 daysCarbon tetrachloride-induced hepatotoxity in ratsDecrease in ALT, AST and ALP levels, restoration of the normal architecture of the liver tissue with minimal fibrosisAbdel-Salam et al. ([@CR1])0.2 ml/kg of mistletoe + 25 mg/kg of sylimarin, once weeklyIscador Qu (*Viscum album* L.)Fresh herbOak (*Quercus robur* L. and *Quercus petraea* (Matt.) Liebl.)Fermented, aqueous extract380 ng/ml of lectins, 14 mg/ml of viscotoxinesTwo 5 mg ampules, three times weeklySubcutaneously12 months5 patients with chronic hepatitis C6--20 fold reduction in viral load (HCV-RNA) and complete remission of elevated AST and ALT in two out of five patients, an increase of HCV RNA in one patientTusenius et al. ([@CR161])Iscador Qu (*Viscum album* L*.*)Fresh herbOak (*Quercus robur* L. and *Quercus petraea* (Matt.) Liebl.)Aqueous750 ng of lectins10 mg, three times weeklySubcutaneously12 months21 patients with chronic hepatitis CDecrease in ALT and AST during the 12 months treatment and slight increase after treatment endTusenius et al. ([@CR160])Abnoba*Viscum* (*Viscum album* L.)Fresh herbOakAqueous1000 ng of lectins0.15 mg, three times weeklyAbnoba*Viscum* Quercus (*Viscum album* L.)Fresh herbOakAqueous65--3610 ng of lectins (mean weekly dose)Three times a weekSubcutaneously9 months25 patients with chronic hepatitis C and elevated alanine aminotransferase (ALT) levelsNone of the patients had complete or partial normalization of ALT or HCV-RNA levels during treatment period, mean ALT did not change during the studyHuber et al. ([@CR54])*Viscum coloratum* (Kom.) NakaiDried steams and leavesAqueousAlkaloid fraction120 mg/kg, dailyOrally by gastric gavage8 weeksCarbon tetrachloride-induced hepatic fibrosis in ratsDecrease of hepatic fibrosis; reduction in mRNA levels of TGF-β1, procollagen I and TIMPs; increase in TGF-β1, TGF-β1 receptor, phosphorylated Smad 2 and α-SMA proteins in liver tissues; increase in Smad 7 levelJiang et al. ([@CR64])Antiepileptic activity*Viscum album* LFresh leavesCitrusAqueous50 and 150 mg/kgOrallyMaximum electro shock, isoniazid- and pentylenetetrazole-induced seizures in mice and ratsReduction in various phases of epileptic seizures, increased latency to the first convulsion, increased convulsion onset and reduction in seizure durationGupta et al. ([@CR44])*Viscum album* LDried herbMaple (*Acer platanoides* L.)Aqueous and aqueous-ethanolic100 mg/kgIntragastrically2 daysPentylenetetrazole-induced seizures in miceEffective against pentylenetetrazole-induced seizuresTsyvunin et al. ([@CR157])Willow (*Salix alba* L.)EthanolicViscum Mali e planta tota *(Viscum album* L.*)*Apple treeInitially given in strength D5, 10 granulesBID, equivalent to a 1:100,000 dilution of the whole plant extract, later increased to D2, equivalent to a 1:100 dilution, 10 granules twice a day12 weeks4½-year-old girl suffering from childhood absence epilepsyThe dose increase of Viscum Mali, in addition to an existing combination with valproic acid and clobazam, may have played a key role in achieving seizure freedom for this childvon Schoen-Angerer et al. ([@CR167])*Viscum capense* L. fDried stemsMethanolic50 and 100 mg/kgIntraperitoneallyPentylenetetrazole-, bicuculline- and N-methyl-DL-aspartic acid- induced seizures in miceDelayed the onset of pentylenetetrazole---and bicuculline-induced seizures and reduction in the number of convulsing animals; moderate effect against N-methyl-DL-aspartic acid-induced tonic seizuresAmabeoku et al. ([@CR4])*Viscum articulatum* Burm. fDried herbMethanolic100 and 200 mg/kg, dailyOrally7 daysMaximum electro shock- and pentylenetetrazole- induced seizures in ratsReduction in duration of hind limb extensor phase and increase in the latency to convulsionsGeetha et al. ([@CR36])*Viscum articulatum* Burm. fFresh herbChloroform and methanolicSyringaresinol150 and 300 mg/kg for extracts, 10 and 20 mg/kg for isolated compoundOrally7 daysPicrotoxin- induced seizures in ratsExtracts and syringaresinol delayed the onset of tonic convulsions, increase in the brain GABA levels in rats treated with the methanolic extractGeetha et al. ([@CR37])N-methyl-[d]{.smallcaps}-aspartic acid---induced seizures in miceOnly the methanolic extract and syringaresinol antagonized the N-methyl-[d]{.smallcaps}-aspartic acid -induced turning behaviourSedative activity*Viscum album* LFresh leavesCitrusAqueous50 and 150 mg/kgOrallyMice placed in actophotometerReduction in locomotor activityGupta et al. ([@CR44])*Viscum album* LFresh leavesCitrusAqueous50 and 150 mg/kgOrallyPentobarbital- induced sleeping time in miceIncrease in duration of sleeping timeGupta et al. ([@CR44])*Viscum album* LDried herbMethanolic and its ethyl acetate and 1-butanol fractions200 and 400 mg/kg for extract, 25 and 50 mg/kg for fractionsOrallyOpen field test on miceReduction in rearing and crossingsKumar et al. ([@CR89])*Viscum orientale* WilldDried leaves*Exoecaria agalloch*Methanolic300 and 500 mg/kgOrallyOpen field test and hole cross test in miceReduction in spontaneous motor activitiesKhatun et al. ([@CR71])Hypnotic activity*Viscum album* LDried herbMethanolic and its ethyl acetate and 1-butanol fractions200 and 400 mg/kg for extract, 25 and 50 mg/kg for fractionsOrallyThiopentone sodium induced-sleeping time assay in miceIncrease in the duration of sleep in miceKumar et al. ([@CR89])Antipsychotic activity*Viscum album* LFresh leavesCitrusAqueous50 and 150 mg/kgOrallyApomorphine-induced stereotypy in mice and ratsSignificantly reduction in the stereotyped behaviourGupta et al. ([@CR44])*Viscum album* LFresh leavesCitrusAqueous50 and 150 mg/kgOrallyHaloperidol-induced catalepsy in mice and rats (bar test)Enhancement in cataleptic effect of haloperidolGupta et al. ([@CR44])Antianxiety activity*Viscum album* LDried herbMethanolic and its ethyl acetate and 1-butanol fractions50 and 100 mg/kg for extract, 5 and 10 mg/kg for fractionsOrallyElevated plus-maze test on mice (EPM model)The number of entries and time spent in open arms in the elevated plus-maze test were significantly increasedKumar et al. ([@CR89])Antistress activity*Viscum album* LDried herbMethanolic and its ethyl acetate and 1-butanol fractions200 and 400 mg/kg for extract, 25 and 50 mg/kg for fractionsOrallyCold swim test on miceReduction in time spent by mice in the immobile stateKumar et al. ([@CR89])Antidepressant activity*Viscum album* LDried herbMethanolic and its ethyl acetate and 1-butanol fractions200 and 400 mg/kg for extract, 25 and 50 mg/kg for fractionsOrallyDespair swim test on miceReduction in the duration of immobility in miceKumar et al. ([@CR89])Analgesic activity*Viscum album* LDried herbMethanolic and its ethyl acetate and 1-butanol fractions200 and 400 mg/kg for extract, 25 and 50 mg/kg for fractionsOrallyTail immersion test was conducted by recording tail withdrawal from heat (flicking response) in miceSignificant analgesic activityKumar et al. ([@CR89])*Viscum album* LDried leaves and stemsApricot (*Armeniaca vulgaris* Lam.)Ethyl acetate2′-Hydroxy-4′,6′-dimethoxy-chalcone-4-*O*-*β-d*-glucopyranoside and 5,7-dimethoxy-flavanone-4′-*O*-\[*β*-D-apiofuranosyl-(1 → 2)\]-*β*-D-glucopyranoside125 and 250 mg/kg for extract and 30 mg/kg for isolated compoundsOrallyp-Benzoquinone-induced writhing test in mice and carrageenan-induced hind paw edema model in miceEthyl acetate fraction and isolated compounds exhibited antinociceptive and anti-inflammatory activityOrhan et al. ([@CR122])*Viscum orientale* WilldDried leaves*Exoecaria agalloch*Methanolic300 and 500 mg/kgOrallyAcetic acid-induced writhing model in mice and formalin-induced paw licking in miceWrithing and paw licking inhibitionKhatun et al. ([@CR71])Alzheimer's disease*Viscum album* LDried leavesOrange treeAqueous100 mg/kg, dailyOrally21 daysAluminum chloride-induced Alzheimer's disease in miceIncrease in the brain-derived neurotrophic factor (BDNF); reduction of aluminum chloride-induced memory impairment and oxidative damageAdemola et al. ([@CR201]) and Ekpenyong et al. ([@CR24])*Viscum coloratum* (Kom.) NacaiDried herbMethanolic25 and 50 mg/kg, dailyOrally7 daysIntracerebroventricular injection of amyloid β protein in miceProtection from memory impairment induced by intracerebroventricular injection of amyloid β proteinJang et al. ([@CR62])MoodEurixor *(Viscum album* L.*)*Fresh herbAqueousLectin (ML-1)1 ng/kg body weight, twice a weekSubcutaneously12 weeksBreast cancer patients (n = 36)Increased levels of plasma beta-endorphinHeiny and Beuth [@CR49])Eurixor *(Viscum album* L.*)*Fresh herbAqueousLectin (ML-1)0.5--1.0 ng /kg body weight, twice a weekSubcutaneously24 weeksBreast cancer patients (n = 47)Increased levels of plasma beta-endorphinHeiny et al. ([@CR50])Antiobesity activity*Viscum coloratum* (Kom.) NacaiDried herbOakAqueous3 g/kg, dailyOrally15 weeksHigh-fat diet-induced obesity in miceReduction in body and epididymal fat pad weightsJung et al. ([@CR65])*Viscum coloratum* (Kom.) NacaiDried herbOakAqueous and ethanolicBetulin and oleanolic acidDiet containing 0.2 or 0.6% of extractOrally8 weeksPartial pancreatectomized ratsReduction in epididymal fat mass by increasing fat oxidationKo et al. ([@CR87])Endurance capacity*Viscum coloratum* (Kom.) NacaiDried herbOakAqueous3 g/kg, dailyOrally15 weeksEndurance test with treadmill in high-fat diet- induced obesity miceMistletoe treated mice run twice as far as high-fat diet miceJung et al. ([@CR65])*Viscum coloratum* (Kom.) NacaiDried herbOakAqueous400 and 1000 mg/kg, daily1 weekEndurance test with treadmill in miceMistletoe treated mice run 2.5-times longer than control mice, plasma lactate levels of exhausted mice were significantly lowerJung et al. ([@CR66])25---400 mg/kg, dailyForced swim test in miceThe swimming time to exhaustion was prolonged by as much as 212%*Viscum coloratum* (Kom.) NacaiLeavesOakAqueous500 mg/kg, dailyOrally2 weeksEndurance test with treadmill in miceDecreases in level of plasma lactate dehydrogenase, increase in the plasma FFA levelLee et al. ([@CR94])*Viscum coloratum* (Kom.) NacaiWhole plantAqueousdiet Containing 0.3 and 1.5% of extractOrally4 weeksTreadmill and swimming pool tests in miceIncreased swimming activity and elevated running times on the treadmillJeong et al. ([@CR63])Activity against muscle decline*Viscum coloratum* (Kom.) NacaiWhole plantAqueous200 and 500 mg/kg, twice a dayOrally by gavage15 daysDenervated miceDecrease in denervation, decrease in the expression of Atrogin-1, no effect on Murf1 expressionJeong et al. ([@CR63])Diet containing 0.3 and 1.5% of extract4 weeksMiceIncreased whole body weights, a higher weight of quadricepses, increased grip strengths, increased swimming activity and elevated running times on the treadmill, increased skeletal muscle area and diameter*Viscum coloratum* (Kom.) NacaiWhole plantAqueous1 and 2 g/dOrally12 weeksRandomized controlled trial with 67 patients aged 55--75Significant differences were found in atrogin-1 mRNA, myogenin mRNA and insulin growth factor 1 receptor phosphorylationLim et al. ([@CR97])Nephroprotective activityHelixor M (*Viscum album* L.)Fresh herbApple tree (*Malus domestica* Borkh.)Aqueous5 mg/kgIntraperitoneally10 daysMethotrexate-induced acute oxidative stress and nephrotoxicity in ratsImprovement in the glutathione peroxidase and superoxide dismutase activities, decrease in the NO and myeloperoxidase levels was not significantSakalli Çetin et al. ([@CR134])*Viscum articulatum* Burm. f*Cordia macleodii* Hook.f. & ThomsonOleanolic acid40, 60 and 80 mg/kg, dailyOrally8 daysGentamicin-induced nephrotoxicityDecrease in serum and urine levels of creatinine, albumin and ureaPatil et al. ([@CR129])Diuretic activity*Viscum angulatum* B.Heyne ex DCDried herb*Randia dumetorum* (Retz.) LamMethanolic100, 200 and 400 mg/kgOrally24 hRatsDose-dependent increase in urine excretion volume, significant saluretic and natriuretic activity, the Cl(-)/Na( +) + K( +) ratio, which indicates carbonic anhydrase mediated activity remained unaffectedJadhav et al. ([@CR59])*Viscum articulatum* Burm. fDried herb*Cordia macleodii* Hook.f. & ThomsonMethanolic100, 200 and 400 mg/kgOrally24 hRatsDose-dependent increase in urine excretion volume, significant saluretic and natriuretic activity(Jadhav et al. ([@CR58])Wound healing*Viscum album* LLiphohilic extractOintmentTopical treatment12 patients with 15 BCC lesionsAchievement of hemostasis in bleeding tumor wounds and after a prolonged treatment period a wound epithelialization with a thin epithelial layerKunz et al. ([@CR90]) and Kuonen et al. ([@CR91])*Viscum articulatum* Burm. fWhole plantEthanol1% extract ointmentIncision, excision and dead space wound model in ratsReduction in wound area, faster re-epithelization rateGarg et al. ([@CR35])Antiulcer activity*Viscum articulatum* Burm. fDried herbMethanolic200 and 400 mg/kgorallyEthanol-induced ulcer model and pylorus ligation ulcer model in ratsInhibition of the gastric lesionsNaganjaneyulu et al. ([@CR105])Antibacterial activity*Viscum album* LDried leavesCocoaMethanolic1000 mg/kg, daily7 daysRats with infections of *Staphylococcus aureus* + *Bacillus cereus*, *Escherichia coli* + *Pseudomonas aeruginosa*, *S. aureus* + *P. aeruginosa* and infection of *E. coli*Heamatological and histopathological analyses showed therapeutic effects of the extractYusuf et al. ([@CR171])Fig. 2Mechanism of cardiac activity of mistletoe. Mistletoe compounds acting on receptor of endothelial cell might activate influx of Ca^2+^ ions leading to activation of NOS. NOS catalyzes formation of NO from L-arginine. NO diffuses to smooth muscle cell. Once sGC is activated by NO, GTP to cGMP conversion is triggered. cGMP activates PKG leading to reducing intracellular Ca^2+^ (by inhibition of Ca^2+^ influx through ligand gated Ca^2+^ channels and release from cellular stores). Proposed mechanism is confirmed by the fact that mistletoe induces NOS-2 and NOS-3 overexpression which is connected with increase in NO and cGMP production

Antidiabetic activity {#Sec4}
=====================

In vivo studies on rats showed that *Viscum* species exhibit antiglycemic and insulinotropic activity by decreasing blood glucose level and increasing the insulin secretion (Ohiri et al. [@CR118]; Nwaegerue et al. [@CR110]; Eno et al. [@CR27]; Shahaboddin et al. [@CR143]; Abdel-Sattar et al. [@CR2]; Adaramoye et al. [@CR200]; Ibegbulem and Chikezie [@CR57]; Kim et al. [@CR79]; Turkkan et al. [@CR159]) (Table [2](#Tab2){ref-type="table"}). Furthermore, the effects of mistletoe have been shown to be dependent on host trees (Orhan et al. [@CR121]; Umoh et al. [@CR164]). The antilipidemic activity of mistletoe was shown in the reduction in low density lipoprotein cholesterol (LDL) and the increase in high density lipoprotein cholesterol (HDL) (Abdel-Sattar et al. [@CR2]; Adaramoye et al. [@CR200]; Kim et al. [@CR80]) as well as improvement of HOMA-IR (Homeostatic Model Assessment of Insulin Resistance), which is an indicator of insulin resistance (Kim et al. [@CR80]). Gray and Flatt ([@CR43]) showed that aqueous extract of *Viscum album* L. exhibited dose-dependent activity to stimulate insulin secretion by rat clonal pancreatic β-cells, and the effect was not mediated by lectins. Furthermore, Kim et al. ([@CR79]) showed that Korean mistletoe growing on oak increased the insulin secretion from the rat pancreatic β-cells (RINm5F cells) without any effects of cytotoxicity. The lectin-free protein fraction induced insulin secretion was similar to the Korean mistletoe extract. It was also reported that the protein fraction upregulated pancreatic and duodenal homeobox 1 (PDX-1) and beta2 (neuroD), which are transcription factors regulating the expression of insulin gene. An ethanolic extract of Korean mistletoe growing on oak also made β-cell mass greater by increasing β-cell proliferation and decreasing its apoptosis. An in vitro study showed that betulin potentiated insulin-stimulated glucose uptake by increasing PPAR-γ (peroxisome proliferator-activated receptor γ) activity and insulin signalling in 3T3-L1 adipocytes, whereas oleanolic acid enhanced glucose-stimulated insulin secretion and cell proliferation in insulinoma cells (Ko et al. [@CR87]). Aqueous *Viscum coloratum* (Kom.) Nakai extract significantly increased the secretion of insulin and an insulin precursor, C-peptide, by RINm5F cells. In differentiated C2C12 cells, the extract enhanced the expression of glucose transporter type 4 (GLUT-4), insulin receptor substrate 1 (IRS-1), and protein kinase B (AKT), which are involved in the glucose uptake signalling pathway. Viscothionin, a polypeptide isolated from mistletoe, increased the level of insulin secretion by more than 20-fold compared to that induced by the extract (Park et al. [@CR125]). Furthermore, it was reported that mistletoe extracts inhibited α-glucosidase activity, an enzyme catalysing the cleavage of glucose from disaccharide, impeding the digestion and adsorption of glucose, eliciting attenuated postprandial plasma glucose levels (Önal et al. [@CR119]; Park et al. [@CR125]). The mechanism of action is shown on Fig. [3](#Fig3){ref-type="fig"}.Fig. 3Mechanism of antidiabetic activity of mistletoe. Mistletoe increases the secretion of insulin and insulin precursor, C-peptide. Insulin binds to tyrosine kinase receptor (RTK). The activated receptor phosphorylates the IRS-1 protein leading to activation of PI3K which catalyzes the addition of phosphate group to PIP2, converting it to PIP3. PIP3 activates PDK1 leading to AKT phosphorylation, recruitment of the glucose transporter GLUT-4 to the membrane and glucose inflow. Mistletoe enhances the expression of GLUT-4, IRS-1 and AKT. Furthermore, protein fraction of mistletoe upregulates transcription factors PDX-1 and beta2 (neuroD). PDX-1 and beta2 become phosphorylated (this process might be mediated by PI3K and ERK1/2 pathways) and regulate insulin gene transcription

Hepatoprotective activity {#Sec5}
=========================

Indicators of liver cell injury are increased levels of serum aminotransferases, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as well as alkaline phosphatase (ALP). Studies on rats with hepatic damage showed that *Viscum* species decreased levels of ALT, AST and ALP (Abdel-Salam et al. [@CR1]; Ogbonnanya et al. [@CR116]; Yusuf et al. [@CR170]) (Table [2](#Tab2){ref-type="table"}). Furthermore, aqueous extracts of leaves of *Viscum album* L. growing on citrus decreased levels of serum bilirubin in high-salt-fed rats and in streptozotocin-induced diabetic rats (Nna et al. [@CR108]; Ofem et al. [@CR115]). The results of studies on patients with chronic hepatitis C were ambiguous. Treatment with either Iscador or Abnoba*Viscum* caused significant improvement for AST and ALT (Tusenius et al. [@CR160]). Furthermore, in two out of five patients treated with Iscodar, a 6--20 fold viral load reduction (HCV-RNA) and improvements for AST and ALT were observed (Tusenius et al. [@CR161]). On the other hand, none of the patients with chronic hepatitis C and elevated ALT levels had complete or partial normalization of ALT or HCV-RNA levels during treatment with Abnoba*Viscum* Quercus (Huber et al. [@CR54]). The mechanism of hepatoprotection by mistletoe is not clear, but it might be mediated by the TGF-β/Smad pathway (Fig. [4](#Fig4){ref-type="fig"}). It is accepted that hepatic fibrosis is characterized by an excessive accumulation of extracellular matrix (ECM) proteins. Transforming growth factor-β1 (TGF-β1) is a cytokine leading to the activation of hepatic stellate cells (HSCs), and it stimulates ECM production while inhibiting its degradation. Once activated, TGF-β1 binds its cognate receptors and functions in autocrine and paracrine manners to exert its activities via Smad-dependent and -independent pathways. Smads are signal transduction molecules transmitting signals directly from cell surface receptors to the nucleus. Smad signal transduction pathways are thought to mediate TGF-β1-induced collagen synthesis and to play a crucial role in the process of liver damage. Nine Smads have been reported and classified into three groups. When TGF-β1 binds to its receptor, Smad 2/3 is phosphorylated and binds with Smad 4, and they move together into the nucleus for translation and expression of the target gene. Smad 7 is an inhibitory Smad that negatively regulates Smad 2/3 activation and functions by targeting the TGF-β1 receptor. An in vivo study on rats with carbon tetrachloride-induced hepatotoxicity showed that TGF-β1, TGF-β1 receptor and phosphorylated Smad 2 protein levels were reduced and Smad 7 level was increased after treatment with mistletoe alkaloid fractions. The mRNA levels of collagen I and tissue inhibitors of metalloproteinases (TIMP-1) were also downregulated. Collagen I is the prototype constituent of the fibril-formatting matrix in fibrotic liver, whereas TIMP-1 is an endogenous inhibitor of the matrix metalloproteinase (MMP) degradation of ECM. Furthermore, the mistletoe alkaloid fractions blocked α-SMA (α smooth muscle actin), the marker of activated HSC. An in vitro study on HSC-T6 cells showed that treatment with mistletoe alkaloid fractions induced Smad 7 expression and inhibited the expression of α-SMA, TGFβ1, TGF-β1 receptors, Smad 2 and TIMP-1 (Jiang et al. [@CR64]).Fig. 4Mechanism of hepatoprotective activity of mistletoe, TGFβ/Smad pathway. TGFβ1 binds to its receptor, which consists of two type I and two type II subunits. Type II subunit phosphorylates type I subunit, which then phosphorylates Smad 2 and Smad 3. Phosphorylated Smad 2 and Smad 3 bind with Smad 4 and together they move into the nucleus to regulate expression of target genes. Smad 7 is an inhibitory Smad that negatively regulates Smad 2/3 activation. In vivo study showed that mistletoe alkaloid fractions downregulate TGF-β1, TGF-β1 receptor, phosphorylated Smad 2 and α-SMA proteins as well as downregulate the mRNA levels of TGF-β1, collagen I and TIMP-1. In contrast, Smad 7 level is upregulated. In vitro study showed that mistletoe alkaloid fractions induce Smad 7 expression and inhibit the expression of α-SMA, TGFβ1, TGF-β1 receptor, Smad 2 and TIMP-1

Neuropharmacological activity {#Sec6}
=============================

The influence of *Viscum* species on the central nervous system (CNS) is differential, and it was reviewed by Szurpnicka et al. ([@CR152]) In vivo studies on mice and rats showed that *Viscum* species exhibited antiepileptic (Amabeoku et al. [@CR4]; Geetha et al. [@CR36], [@CR37]; Gupta et al. [@CR44]; Tsyvunin et al. [@CR157]), sedative (Gupta et al. [@CR44]; Khatun et al. [@CR71]; Kumar et al. [@CR89]), analgesic (Orhan et al. [@CR122]; Khatun et al. [@CR71]), antianxiety, antidepressant, hypnotic, anti-stress (Kumar et al. [@CR89]) and antipsychotic activity (Gupta et al. [@CR44]) (Table [2](#Tab2){ref-type="table"}). Several studies have proposed that the CNS activity of mistletoe is mediated by GABA (γ-aminobutyric acid) receptors. GABA is the most important inhibitory neurotransmitter in the human central nervous system. GABA is involved in epilepsy, sedation and anxiolysis, and it works by binding to GABA~A~ receptors. GABA~A~ receptors are heteromeric GABA-gated chloride channels. The transmembrane ion channel is opened by a stimulus generated by GABA, which allows an influx of chloride ions. This results in a decrease of the depolarizing effects of an excitatory input, thereby depressing excitability. As a result, the cell is inhibited and an anticonvulsant, sedative or anxiolytic activity is achieved. The type of activity obtained depends on the subtype of the receptor. The GABA~A~ receptor consists of five subunits, made up of two α, two β and one γ or δ subunit. Several isoforms exist (α1--α6, β1-β3, γ1--γ3, δ), potentially giving a vast number of combinatorial mixes. However, only ten subunit combinations make up the physiologically relevant GABA~A~ receptors in the brain (Jäger and Saaby [@CR60]). In addition to GABA binding sites, the GABA~A~ receptor possesses binding sites for compounds that allosterically modify the chloride channel gating of GABA, such as benzodiazepines and barbiturates. Benzodiazepine site agonists increase the GABA-induced chloride channel opening frequency and have established efficacy in the treatment of anxiety, insomnia and epilepsy as well as muscle relaxant, sedative, hypnotic, and cognition impairing effects (Diniz et al. [@CR22]) (Fig. [5](#Fig5){ref-type="fig"}). Furthermore, it has been reported that mistletoe extract standardized for galactoside-specific lectin (ML-1) increases the beta-endorphin plasma levels in breast cancer patients (Heiny and Beuth [@CR49]; Heiny et al. [@CR50]). Endorphins act through opiate receptors. Three major type of opioid receptors have been identified, mu (μ), delta (δ) and kappa (κ). Beta-endorphin has a relatively high affinity at mu and delta receptors. Mu (μ) (agonist morphine) receptors are responsible for supraspinal analgesia, respiratory depression, euphoria, sedation, decreased gastrointestinal motility and physical dependence (Sharma et al. [@CR144]). Treatment with an aqueous extract of *Viscum album* L. might also increase brain-derived neurotrophic factor (BDNF) (Ademola et al. [@CR201]; Ekpenyong et al. [@CR24]). BDNF plays a prominent role in modulating cognition and memory. BDNF is a neurotrophin that belongs to a family of proteins that promote the survival, functions and development of neurons. BDNF enhances neurogenesis and neurotransmission across the synapses, promotes synaptic growth and modulates synaptic plasticity (Fig. [6](#Fig6){ref-type="fig"}). BDNF also induces hippocampal long-term potentiation, which is important for memory formation. It was found that higher peripheral BDNF levels protect the older adults against Alzheimer's disease (Ng et al. [@CR106]).Fig. 5Mechanism of neuropharmacological activity of mistletoe, GABAergic signalling. Mistletoe compounds might be positive allosteric modulators of GABA~A~ receptor. They might bind to benzodiazepine site increasing the binding affinity of the receptor for GABA. This results in increased frequency of chloride ion channel opening, increased influx of chloride ions and hyperpolarization leading to anticonvulsant, sedative and anxiolytic activityFig. 6Mechanism of neuropharmacological activity of mistletoe, BDNF signalling. Mistletoe has been reported to increase brain-derived neurotrophic factor (BDNF) level. BDNF binds to tyrosine receptor kinase B leading to its phosphorylation and activation of signaling pathways. The P13K pathway activates AKT leading to neuronal survival whereas MAPK/ERK pathway leads to neuronal growth and differentiation

Antiobesity activity {#Sec7}
====================

Treatment with mistletoe parasitizing oak might influence body and epididymal fat pad weights in vivo and inhibit adipogenic factors in vitro (Table [2](#Tab2){ref-type="table"}). It is known that obesity is related with adipocyte differentiation and the extent of subsequent fat accumulation. Adipogenesis can be induced through the action of enzymes, such as fatty acid synthase (FAS), acyl-CoA synthase (ACC) and acyl-CoA synthetase (ACS). The expressions of these genes are regulated by transcription factors, including peroxisome proliferator-activated receptor γ (PPAR-γ), CCAAT/enhancer-binding protein-α (C/EBP-α) and sterol regulatory element binding element protein-1c (SREBP-1c), which are known to be crucial activators for adipogenesis and show early changes in gene expression during adipocyte differentiation (Jung et al. [@CR65]). It has been shown that mistletoe treatment significantly decreased SREBP-1c, C/EBP-α, and PPAR-γ mRNA expression in cultured 3T3-L1 adipocytes and inhibited expression of adipocyte-specific proteins---FAS, ACC, ACS, and LPL (lipoprotein lipase) (Jung et al. [@CR65]). Furthermore, in ovariectomized rats fed a high-fat diet, Korean mistletoe decreased FAS and SREBP-1c expression as well as increased carnitine palmitoyltransferase-1 (CPT-1) expression, a key regulator of fatty acid oxidation (Kim et al. [@CR80]) (Fig. [7](#Fig7){ref-type="fig"}).Fig. 7Probable mechanism of antiobesity activity of mistletoe. LPL converts triacylglycerides into free fatty acids. Free fatty acids are moved into the cell and activated to acyl-CoA. CPT1 converts acyl-CoA to acylcarnitine, which is transported into the mitochondria by CAT. CPT2 converts acylcarnitine back to acyl-CoA, and then acyl-CoA enters β-oxidation pathway. Acetyl-CoA goes into TCA cycle. Citrate exits mitochondria and is converted to acetyl-CoA, which is carboxylated to malonyl-CoA by ACC. FAS undergoes the reductive synthesis of palmitate which is converted to palmitiyl-CoA leading to formation of triacylogliceryes. Additionally, malonyl-CoA inhibits CPT-1. Mistletoe decreases expression of FAS, ACC, ACS and LPL and decreases SREBP-1c, C/EBP-α, and PPAR-γ mRNA expression

Muscle mitochondrial activity {#Sec8}
=============================

It was determined that the administration of an aqueous extract of Korean mistletoe might enhance exercise performance in mice (Jung et al. [@CR66], [@CR65]; Lee et al. [@CR94]) (Table [2](#Tab2){ref-type="table"}). Jung et al. ([@CR66]) showed that an increase in endurance capacity might be mediated by improvement of mitochondrial biogenesis (Fig. [8](#Fig8){ref-type="fig"}). Korean mistletoe treatment significantly increased the mitochondrial oxygen consumption rate (OCR) in L6 cells (rat myoblast cell line) as well as increased the mRNA expression of peroxisome proliferator-activated receptor γ coactivator (PGC-1α) and silent mating type information regulation 2 homolog 1 (SIRT-1), two major genes related to mitochondrial biogenesis and function in C2C12 cells (mouse myoblast cell line). Korean mistletoe treatment increased the expression of PGC-1α transcriptional targets, such as PGC-1β, NRF-1 (nuclear respiratory factor-1), ERRα (estrogen-related receptor α), Tfam (mitochondrial transcription factor A), PPARβ/δ (peroxisome proliferator--activated receptor β/δ), MB (myoglobin) and TNNI2 (troponin I) in C2C12 cells. Additionally, Korean mistletoe decreased levels of plasma lactate and lactate dehydrogenase, parameters of tissue damage and muscle fatigue in exhausted mice (Jung et al. [@CR66]; Lee et al. [@CR94]). Furthermore, exercise training increases the muscular glycogen and plasma free fatty acid (FFA) level, and Korean mistletoe administration increased the plasma FFA level, indicating that Korean mistletoe administration alters the energy resources in muscle (Lee et al. [@CR94]).Fig. 8Probable effect of mistletoe on muscle mitochondrial activity. Two major genes related to mitochondrial biogenesis and function are SIRT-1 and PGC-1α. PGC-1α translocates into the nucleus where it is phosphorylated by AMPK and deacetylated by SIRT-1. Once phosphorylated and deacetylated, PGC-1α activity is increased, leading to increased transcription of mitochondrial genes. Korean mistletoe increases the mRNA expression of PGC-1α and SIRT-1 and increases the expression of PGC-1α transcriptional targets such as PGC-1β, NRF-1, ERRα, Tfam, PPARβ/δ, myoglobin and TNNI2

Activity against muscle decline {#Sec9}
===============================

Supplementation with mistletoe might be effective against age-related decline in muscle mass (Table [2](#Tab2){ref-type="table"}). An in vitro study showed that an aqueous extract of Korean mistletoe caused higher phosphorylation of AKT in C2C12 cells (mouse myoblast cell line), suggesting that mistletoe has an effect on the regulation of the muscle mass through the activation of the AKT/mTOR (protein kinase B/ mammalian target of rapamycin) signalling pathway (Jeong et al. [@CR63]) (Fig. [9](#Fig9){ref-type="fig"}). Furthermore, mistletoe showed increased phosphorylation of FoxO (forkhead box transcription factors of the class O) supporting the observation that mistletoe could induce the phosphorylation of AMPK (AMP-activated protein kinase), which is a repressor of FoxO. FoxO is a key molecule inducing muscle atrophy by stimulating the E3 ubiquitin ligases Murf1 and Atrogin-1. In C2C12 cells, as well as in denervated mice, mistletoe decreased gene expression of Atrogin-1. On the contrary, in C2C12 cells, mistletoe increased mRNA expression of PGC-1α, GLUT-4, and SREBP-1c genes related to the inhibition of muscle atrophy and related to the induction of muscle hypertrophy by regulating the expression of Atrogin-1and Murf1 (Jeong et al. [@CR63]). Lim et al. ([@CR97]) conducted randomized controlled trial confirming that supplementation with Korean mistletoe extract and exercise affects muscle mass and functional capabilities. Supplementation with tablets containing aqueous extracts of *Viscum coloratum* (Kom.) Nakai was effective for suppressing intracellular pathways related to muscle protein degradation, but stimulated those related to myogenesis. The mRNA expressions levels related to muscle protein degradation (REDD2, TSC2, FoxO1, and atrogin-1) and myogenesis (mTOR, S6K1Rheb, c-Myc, myogenin, and MyoD) as well as the phosphorylation of proteins related to muscle protein degradation (GSK3β, GSK3α, TSC2, and PTEN) and myogenesis (IGF1R, IR, IRS-1, AKT, mTOR, P70S6K, RPS6 and ERK) were studied. Significant differences were found in atrogin-1 mRNA, myogenin mRNA and insulin growth factor 1 receptor phosphorylation. A single administration of mistletoe induced decreases in atrogin-1 gene expression and PTEN (phosphatase and tension homolog) phosphorylation and an increase in myogenin gene expression. A 12-week treatment induced consistent changes in atrogin-1 and myogenin gene expression. Furthermore, the increase of REDD2 gene expression and a decrease of IGF1R phosphorylation shown by the placebo group were retarded in the mistletoe treated group at a 12-week administration. In patients treated with mistletoe, along with an endurance exercise program, the body composition was significantly changed, and knee strength and the dynamic balance ability were improved (Lim et al. [@CR97]).Fig. 9Probable effect of mistletoe against muscle decline. IGF1 binds to IGF1 receptor leading to activation of PI3K/AKT/mTOR pathway. Mistletoe leads to higher phosphotylation of AKT resulting in activation of P70S6K, upregulation of myoD and myogenin expression and myogenesis. Mistletoe decreases phosphorylation of PTEN which dephosphorylates PIP~3~, increasing PIP~2~ level and resulting in a decreased AKT activity. Furthermore, mistletoe decreases expression of REDD2 which inhibits mTOR pathway*.* Mistletoe increases phosphorylation of FoxO supporting the observation that mistletoe could induce the phosphorylation of AMPK, which is a repressor of FoxO. AKT also causes phosphorylation and nuclear exclusion of FoxO which is key molecule inducing muscle atrophy by stimulating Murf1 and Atrogin-1. Additionally, FoxO-dependent activation of muscle atrophy is inhibited by PGC-1α

Antioxidative activity {#Sec10}
======================

Oxidative stress, defined as an imbalance between oxidants and antioxidants in favour of oxidants, leads to many biochemical changes in organisms and is an important contributing factor in several human chronic diseases, such as atherosclerosis and cardiovascular diseases, mutagenesis and cancer, several neurodegenerative disorders, and aging process (Frei [@CR32]). It is suggested that increasing intake of dietary antioxidant may help to maintain a tolerable antioxidant status and help in the disease prevention (Nimse and Pal [@CR107]). Numerous mistletoe extracts and isolated lectin showed radical-scaveging activity and protective effects against oxidative stress induced by free radicals, nitric oxide and superoxide anion (O~2~^−^) (Sengul et al. [@CR141]; Papuc et al. [@CR124]; Kim et al. [@CR75], [@CR81]; Kusi et al. [@CR92]). It was studied that the activity of the more polar extracts was higher in different antioxidant mechanism and might result from high level of phenolic and flavonoid compounds (Orhan et al. [@CR123]; Khatun et al. [@CR71]; Pietrzak et al. [@CR130]). Furthermore, antioxidant activity of *Viscum* species depends on host tree (Vicas and Prokisch, [@CR165]; Vicas et al. [@CR166]; Orhan et al. [@CR123]; Pietrzak et al. [@CR130]) and the time of harvest (Önay­Uçar et al. [@CR120]).

Nephroprotective and antidiuretic activity {#Sec11}
==========================================

Helixor M, extract from *Viscum album* L. growing on apple tree, showed activity against methotrexate (MTX)-induced acute oxidative stress and nephrotoxicity in rats. The mechanism included antioxidant and anti-inflammatory properties, as evident from significant increase in the activities of the antioxidative enzymes, superoxide dismutase (SOD) and glutathione peroxidise (GSH-Px) (Sakalli Çetin et al. [@CR134]). Oleanolic acid isolated from *Viscum articulatum* Burm. f. showed protective effects on gentamicin-induced renal damage in rats. Oleanolic acid decreased creatinine, albumin and urea levels in the serum and urine. It protected the rat kidneys from histological alterations induced by gentamicin and improved the glomerular filtration rate. The mechanism might be due to antioxidant and diuretic activity (Patil et al. [@CR129]). Diuretic activity was tested for *Viscum angulatum* B. Heyne ex DC. and *Viscum articulatum* Burm. f. It was showed that mistletoe had a significant effect on the urine excretion volume. The higher natriuretic activity (Na^+^/K^+^) observed suggested a potassium-sparing diuretic effect. Furthermore, the extract showed less influence on the ion quotient (Cl^−^/Na^+^ + K^+^) which suggested no inhibition of carbonic anhydrase (Jadhav et al. [@CR58], [@CR58]).

Wound healing {#Sec12}
=============

*Viscum articulatum* Burm. f., extract showed reduction in wound area in an excision wound model in rats (Table [2](#Tab2){ref-type="table"}). Furthermore, the re-epithelization rate was found to be faster and granuloma breaking strength as well as dry granulation tissue were significantly increased in extract-treated rats (Garg et al. [@CR35]). Kunz et al. ([@CR90]) showed in a prospective case series study, wound healing promoting and anti-tumour effects by the topical treatment of basal cell carcinoma with ointment containing *Viscum album* L. lipophilic extract. More specifically, an achievement of haemostasis in bleeding tumour wounds, and after a prolonged treatment period, a wound epithelialization with a thin epithelial layer (Kuonen et al. [@CR91]). It is known that, in wound healing processes, many different cell types are involved, including fibroblasts and keratinocytes. As fibroblasts are responsible for initiating angiogenesis, epithelialization, collagen formation and synthesis of extracellular matrix proteins an important step of the proliferative phase of wound healing is the activation of fibroblast migration into the wounded area. An in vitro study showed that *Viscum album* L. liphophilic extract and its predominant triterpene--oleanolic acid significantly and dose-dependently promoted the migration of NIH/3T3 fibroblasts, thereby leading to an enhanced wound closure (Kuonen et al. [@CR91]).

Antiulcer activity {#Sec13}
==================

We found a research regarding the antiulcer activity of mistletoe. Methanolic extract of *Viscum articulatum* Burm. f was tested in Pyrolus ligation ulcer and ethanol induced ulcer models in rats. The extract showed significant inhibition of the gastric lesions in both models. Significant reduction in gastric volume, free acidity and ulcer index was observed compared to control. The authors proposed that antiulcerogenic and ulcer healing properties might be due to antisecretory activity of mistletoe (Naganjaneyulu et al. [@CR105]).

Antibacterial activity {#Sec14}
======================

In the need to find new potent antibacterial compounds, the activity of *Viscum* species was examined in vitro using wide selection of bacterial strains such as *Staphylococcus aureus*, *Staphylococcus epidermidis*, *Bacillus subtilis*, *Bacillus atrophaeus, Enterococcus faecium, Escherichia coli, Bordetella bronchisiptica, Salmonella typhi, Pseudomonas aeruginosa, Pseudomonas syringe, Enterobacter cloacae, Proteus vulgaris, Proteus mirabilis, Klebsiella pneumoniae, Klebsiellaaerogenes, Serratiamarcescens, Streptococcus pyogenes, Mycobacterium tuberculosis, Erwinia carotovora, Agrobacterium tumefaciens, Propionibacterium acnes* and *Xanthomonas campestris* (Satish et al. [@CR135]; Deliorman et al. [@CR21]; Erturk et al. [@CR29]; Oguntoye et al. [@CR117]; Sengul et al. [@CR141]; Hussain et al. [@CR56]; Turker et al. [@CR158]; Assaf et al. [@CR5]; Abualhasan et al. [@CR3]; Kusi et al. [@CR92]; Shah et al. [@CR142]). The results obtained are difficult to compare, because researchers used different solvents and various extortion methods to obtain extracts. In addition, some extracts were obtained from the entire plant, and others were obtained from its individual parts such as fruits, leaves or steams (Hussain et al. [@CR56]; Shah et al. [@CR142]). Mistletoe was also obtained from various types of host trees (Deliorman et al. [@CR21]; Turker et al. [@CR158]). Those interested are invited to read the quoted articles. We found only one in vivo study carried out on rats infected by *Staphylococcus aureus* + *Bacillus cereus, Escherichia coli* + *Pseudomonas aeruginosa, Staphylococcus aureus* + *Pseudomonas aeruginosa* and *Escherichia coli*. Haematological and histopathological studies, after 7 days of treatment with methanolic extract of *Viscum album* L. parasitizing cocoa trees, exhibited its therapeutic effect (Yusuf et al. [@CR171]) (Table [2](#Tab2){ref-type="table"}). Researchers have noticed that antibacterial activity of the extracts was more effective against Gram-negative bacteria than against Gram-positive bacteria (Erturk et al. [@CR29]; Hussain et al. [@CR56]) and postulated that the antibacterial effects were through anti-biofilm activity (Kenar et al. [@CR69]).

Antifungal activity {#Sec15}
===================

Antifungal activity was most often tested on *Candida* species, which are important pathogens causing substantial morbidity and mortality in hospitalized critically ill patients (Jahagirdar et al. [@CR61]). Nacsa-Farkas et al. ([@CR104]) tested activity of ethanolic extract of *Viscum album* L. against twelve *Candida* species, of which the most sensitive was *Candida inconspicua* (MIC 5.65 mg/mL). A methanolic extract of *Viscum cruciatum* Sieber ex Boiss. leaves exhibited activity against *Candida albicans* with MIC 1.25 mg/mL (Assaf et al. [@CR5]). Furthermore, an n-hexane extract of *Viscum album* subsp. *abietis* (Wiesb.) Abrom. and its two fractions after flash column preparation were tested against *Candida albicans*. The first fraction was active at a concentration of 1 mg/mL (ZI (zone inhibition) 11 mm), whereas the second fraction showed activity at a concentration of 10 mg/mL (ZI 10 mm) (Erturk et al. [@CR29]). Shah et al. ([@CR142]) compared the activity of different parts of *Viscum album* L. against *Candida albicans*. For steam distillations, the most active was the butanol extract, which showed 25.66 and 30.00 mm ZI at 1 and 2 mg/disc, respectively. For leaves, the methanol extract was the most active, reducing the growth of *Candida albicans* as 25.00 and 30.00 mm ZI at 1 and 2 mg/disc, respectively. For fruits, the most potent was the n-hexane extract, which reduced the growth of *Candida albicans* by 22.00 mm ZI at both concentrations (1 and 2 mg/disc). On the other hand, methanolic, dichloromethane and aqueous extracts of *Viscum capense* L. f. stems had no effect on the growth of *Candida albicans* (Amabeoku et al. [@CR4]). Furthermore, Hussain et al. ([@CR56]) studied various extracts of *Viscum album* L. leaves and twigs and found that they were not effective against *Saccharomyces cerevisiae* and *Aspergillus flavus*. Methanolic extracts of leaves of *Viscum album* L. growing on cocoa and cola trees inhibited the growth of *Fusarium oxysporium, Penicillium oxalium* and *Microsporum canis*, but the highest activity was obtained against *Aspergillus niger* (ZI 10.66 ± 1.45 mm) (Yusuf et al. [@CR172]). The petroleum ether extract of *Viscum album* L. leaves was found to be more effective against *Aspergillus niger*, *Fusarium oxysporium, Botryodiplodia theobromae* and *Geotrichum candidum* than methanolic extract. The highest activity was exhibited by the petroleum ether extract against *Botryodiplodia theobromae* with ZI of 15.85 mm (Akalazu et al. [@CR202]). It was proposed that two compounds, caprylamide and linolelaidic acid methyl ester, might be the major antifungal compounds in the leaves of mistletoe (\*\*\*Akalazu et al. [@CR202]). Other compounds active against fungi might be viscotoxines. Viscotoxin A3 and viscotoxin B, at a concentration of 10 µM, blocked the germination of spores, and at lower concentration than 10 µM, inhibited the mycelial growth of *Fusarium solani, Sclerotinia sclerotiorum* and *Phytophthora infestans*. It was postulated that viscotoxin A3 might bind to membranes and form ion channels, leading to destabilization and disruption of the plasma membrane (Giudici et al. [@CR40], [@CR38], [@CR39]).

Antiviral activity {#Sec16}
==================

So far, the antiviral activity of mistletoe has not been extensively investigated. The aqueous extract of leaves of *Viscum album* L. growing on lime trees was found to be effective against human parainfluenza virus type 2 (HPIV-2) growth in Vero cells. The extract, at a dose of 1 µg/mL, inhibited HPIV-2 replication and suppressed virus production by 99.7% (ED50 0.53 µg/mL) with no toxic effect on host cells (Karagöz et al. [@CR68]). The methanolic extract of *Viscum album* L. leaves was active against measles virus growth in Vero cells at 0.063 μg/*μ*L (IC~50~ 0.031 μg/*μ*L) and 0.031 μg/*μ*L (IC~50~ 0.039 μg/*μ*L). On the other hand, the polio, yellow fever and simplex virus-1 (HSV-1) viruses were resistant to the same extract (Obi and Shenge [@CR111]). Due to the strong impact of mistletoe on the immune system, it was proposed that it might be useful as a complementary treatment of patients with human immunodeficiency virus (HIV). Studies to confirm the induction of immunomodulation and possibility of the inhibition of the progression of HIV disease are needed (Gorter et al. [@CR41], [@CR42]; Stoss and Gorter [@CR149]; Stoss et al. [@CR150]). An in vitro study revealed that a phenolic glycoside, homoeriodictyol-7-*O*-*β*-D-glucopyranoside-4′-*O*-*β*-D-apiofuranoside, isolated from *Viscum articulatum* Burm. f. growing on Fagaceae: *Lithocarpus variolosus* (Franch.) Chunex showed weak anti-HIV-1 activity with CC~50~ \> 200 μg/mL and EC~50~ = 18.09 μg/mL. This compound exerted its weak protection of HIV-1ШB-induced MT-4 host cell lytic effects with a TI \> 11.06 (Li et al. [@CR96]).

Conclusion {#Sec17}
==========

Traditionally mistletoe has been used in a treatment of many diseases. To date, the anticancer and immunomodulatory activities of *Viscum* species were the most studied. In Europe, mainly in German-speaking countries, this resulted in the launch of extracts for subcutaneous or intravenous administration to improve the quality of life and survival of cancer patients. Lately, an extensive number of in vitro and in vivo studies have been conducted to investigate the other pharmaceutical activities of mistletoe. The results of these studies (Table[2](#Tab2){ref-type="table"}) showed that mistletoe might be a potential source of new drugs and complementary therapies to treat hypertension, diabetes, liver diseases, epilepsy and Alzheimer's disease. Furthermore, it might be used to improve endurance and muscle strength, enhance wound healing and as antibacterial and antifungal agent. Such a wide variety of pharmaceutical properties is due to the content of many biologically active compounds from various chemical groups. The chemical composition of mistletoe depends on part of the plant (stem, leaves, fruits) and host species as well as the place and time of harvest. To date, the active compounds responsible for the individual pharmacological activities of mistletoe have not been identified. Further studies on fractionation and isolation of main active compounds and the development of methods of standardization of the extracts are required. Such studies should be conducted for extracts prepared from mistletoe parasitizing various host trees, different harvesting periods and different parts of the plant. In the next step of research, the mechanisms of action need to be tested, not only for individual isolated active compounds, but also for the whole extracts. This is because the therapeutic effect of mistletoe might be a result of the synergistic interactions of various secondary metabolites. Those interactions might include both low-molecular weight compounds (such as phenolic acids, flavonoids and fatty acids) and high-molecular weight substances (such as viscotoxines and lectins). Because of the diverse synergistic interactions, the mechanism of action of mistletoe might include many signalling pathways. Mistletoe might regulate either the same or different targets in various pathways, while acting on membrane receptors, enzymes, ion channels, transporter proteins and transcriptional targets. In this review, we summarized the existing studies on pharmacological activities of *Viscum* species and proposed possible mechanisms of action. Still, this is a new field for scientific research, and further studies on compound isolation and identification, synergistic interactions, metabolism, mechanisms of action and toxicity are required. We believe that due to this research, mistletoe will become a source of new complementary therapies supporting the treatment of many diseases.
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